Evidence map›Paper›PMID 34086250›Full record

ReviewCurrent HIV/AIDS reports2021

Strategies for Successful Clinical Trial Recruitment of People Living with HIV in Low- and Middle-Income Countries: Lessons Learned and Implementation Implications from the Nigeria Renal Risk Reduction (R3) Trial.

Aima A Ahonkhai, Usman J Wudil, Faisal S Dankishiya, Donna J Ingles, Baba M Musa, Hamza Muhammad, Mahmoud U Sani, Aisha M Nalado, Aliyu Abdu, Kabiru Abdussalam and 3 more

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aima A AhonkhaiVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA. aimalohi.a.aahonkhai@vumc.org.ORCID http://orcid.org/0000-0003-0666-4767
Usman J WudilVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA.
Faisal S DankishiyaDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Donna J InglesVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA.
Baba M MusaDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Hamza MuhammadDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Mahmoud U SaniDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Aisha M NaladoDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Aliyu AbduDepartment of Medicine, Bayero University Kano (BUK) and Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Kabiru AbdussalamDepartment of Chemical Pathology, Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Leslie PierceVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA.
C William WesterVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA.
Muktar H AliyuVanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), 2525 West End Ave, Suite, Nashville, TN, 750, USA.

Funding

Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in NigeriaU01DK112271 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, WESTER, C. WILLIAM · 2017 to 2022
$3.2M
HIV Intervention Science Training Program for Underserved Investigators R25MH080665 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, WU, ELWIN · 2007 to 2023
$2.8M
Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) 2D43TW011544 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Aishatu Adamu, Muktar Hassan Aliyu · 2020 to 2026
$2.1M
FIC NIH HHS D43 TW011544NIDA NIH HHS T32 DA037801NIDDK NIH HHS U01 DK112271NIMH NIH HHS R25 MH080665
6 · The paper itself

Abstract

purpose of reviewClinical trials represent a bedrock for measuring efficacy of interventions in biomedical research, but recruitment into clinical trials remains a challenge. Few data have focused on recruitment strategies from the perspective of clinical trial teams, especially in low- and middle-income countries (LMIC), where HIV is most prevalent. RECENT

findingsWe summarized data from the literature and our experience with recruitment for the Renal Risk Reduction trial, aimed at reducing risk of kidney complications among people living with HIV in Nigeria. Using an implementation science framework, we identified strategies that contributed to successful clinical trial recruitment. For strategies that could not be categorized by this framework, we summarized key features according to selected action, actor, target, context, and time. We identified how these identified strategies could map to subsequent implementation outcomes at the patient and provider/health system level, as well as capacity-building efforts to meet needs identified by LMIC partners, which is a priority for success. Our experience highlights the importance of considering implementation outcomes, and the strategies necessary to achieve those outcomes early, in the planning and execution of clinical trials. Clinical trial recruitment can be optimized via methodologies grounded in implementation science.

Indexed as

Developing CountriesHIV InfectionsHumansKidneyNigeriaRisk Reduction BehaviorClinical trial implementationClinical trial recruitmentClinical trial teamsImplementation strategiesPatient navigation, Nigeria

Identifiers

PMID34086250
PMCPMC8650944

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.